Dominant‐negative effects of KCNQ2 mutations are associated with epileptic encephalopathy
Top Cited Papers
- 7 December 2013
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 75 (3) , 382-394
Abstract
Objective: Mutations in KCNQ2 and KCNQ3, encoding the voltage‐gated potassium channels KV7.2 and KV7.3, are known to cause benign familial neonatal seizures mainly by haploinsufficiency. Here, we set out to determine the disease mechanism of 7 de novo missense KCNQ2 mutations that were recently described in patients with a severe epileptic encephalopathy including pharmacoresistant seizures and pronounced intellectual disability.Methods: Mutations were inserted into the KCNQ2 cDNA. Potassium currents were recorded using 2‐microelectrode voltage clamping, and surface expression was analyzed by a biotinylation assay in cRNA‐injected Xenopus laevis oocytes.Results: We observed a clear loss of function for all mutations. Strikingly, 5 of 7 mutations exhibited a drastic dominant‐negative effect on wild‐type KV7.2 or KV7.3 subunits, either by globally reducing current amplitudes (3 pore mutations) or by a depolarizing shift of the activation curve (2 voltage sensor mutations) decreasing potassium currents at the subthreshold level at which these channels are known to critically influence neuronal firing. One mutation significantly reduced surface expression. Application of retigabine, a recently marketed KV7 channel opener, partially reversed these effects for the majority of analyzed mutations.Interpretation: The development of severe epilepsy and cognitive decline in children carrying 5 of the 7 studied KCNQ2 mutations can be related to a dominant‐negative reduction of the resulting potassium current at subthreshold membrane potentials. Other factors such as genetic modifiers have to be postulated for the remaining 2 mutations. Retigabine or similar drugs may be used as a personalized therapy for this severe disease. Ann Neurol 2014;75:382–394Keywords
Funding Information
- European Science Foundation (DFG Le1030/11-1)
- European Science Foundation (G.A.136.11.N (FWO/ESF-ECRP))
- BMBF (IonNeurONet: 01GM1105A)
- BMBF (EuroBFNS: 01GM0804)
This publication has 30 references indexed in Scilit:
- Calmodulin Activation Limits the Rate of KCNQ2 K+ Channel Exit from the Endoplasmic ReticulumJournal of Biological Chemistry, 2009
- Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ ChannelsMolecular Pharmacology, 2009
- KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromesNeurology, 2008
- Nervous system KV7 disorders: breakdown of a subthreshold brakeThe Journal of Physiology, 2008
- The C‐terminus of Kv7 channels: a multifunctional moduleThe Journal of Physiology, 2008
- Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implicationsThe Journal of Physiology, 2008
- Neutralization of a negative charge in the S1–S2 region of the KV7.2 (KCNQ2) channel affects voltage‐dependent activation in neonatal epilepsyThe Journal of Physiology, 2008
- Calmodulin regulates the trafficking of KCNQ2 potassium channelsThe FASEB Journal, 2007
- Subthreshold changes of voltage-dependent activation of the KV7.2 channel in neonatal epilepsyNeurobiology of Disease, 2006
- Molecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant RetigabineThe Journal of Neuroscience, 2005